Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide with R-GDP in R/R DLBCL
NCT03373019Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Dec 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in diffuse large B-cell lymphoma (DLBCL), sponsored by Fudan University. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03373019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03373019.